Letters
Co-proxamol and suicide
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7409.287 (Published 31 July 2003) Cite this as: BMJ 2003;327:287Licence needs to be changed
- D N Bateman, reader in clinical pharmacology (nick.bateman@luht.scot.nhs.uk),
- R Afshari, postgraduate fellow
- Scottish Poisons Information Bureau, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA
EDITOR—We agree with Hawton et al that co-proxamol presents a major overdose hazard, their results illustrating the difficulties for licensing authorities in limiting availability of prescription medicines that are only hazardous in overdose.1
Co-proxamol is more likely to result in death; it causes prolongation …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.